LIFECODES^® C3d Detection Assay

Detect C3d-binding donor specific anti-HLA antibodies (DSAs) for better risk stratification of patients.

Resource Library Learn

Detect C3d-binding donor-specific anti-HLA antibodies (DSAs) for better risk stratification of patients.

The LIFECODES C3d Assay provides a measure of the binding and processing of complement to one of its end products - C3d. When combined with our LIFECODES LSA Single Antigen Kits, the assay offers a simple method for the detection of complement binding to HLA antibodies.

Identifies complement binding antibodies
Streamlines work flow with MATCH IT!^® Antibody software
Utilises highly sensitive Luminex^® xMAP^® technology

Product Name is for Research Use Only (RUO). Not for use in diagnostic procedures.

Enhanced LSA Brochure

C3d Sell Sheet

A Role of Complement Fixing DSA in Allograft Rejection – Evaluation of the Immucor LIFECODES C3d Detection Assay White Paper

Luminex LX200 Support Reassurance Letter

HLA Antibody Identification

Resource Library

PACKAGE INSERTS (PI/ IFU), SAFETY DATA SHEETS (SDS), CERTIFICATES of ANALYSIS, LOT SPECIFIC FILES, and more can be accessed on our customer center.

Our Certifications

View All Certifications

Upcoming Events,
Webinars & Workshops

View Events Calendar

Keep Up With Us

View All News & Blogs

News & Blogs

Werfen Introduces NanoTYPE™ HLA-11 Plus CE— First CE-IVD HLA Typing Kit with Full-Gene Coverage for All 11 Classical HLA Genes

Werfen, a global leader in specialized diagnostics, announced the availability of NanoTYPETM HLA-11 Plus as CE-IVD (according to IVD-R), a next-generation HLA typing assay offering true full-gene coverage — from 5′UTR to 3′UTR — across all 11 classical HLA genes....

Continue Reading View All